BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/31/2016 11:45:00 AM | Browse: 777 | Download: 2767
 |
Received |
|
2016-06-15 15:52 |
|
Peer-Review Started |
|
2016-06-17 09:49 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2016-07-21 11:42 |
|
Revised |
|
2016-07-28 11:15 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2016-08-18 10:00 |
|
Second Decision by Editor-in-Chief |
|
2016-08-19 05:30 |
|
Final Decision by Editorial Office Director |
|
2016-08-29 12:05 |
|
Articles in Press |
|
2016-08-29 12:05 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-10-24 14:27 |
|
Publish the Manuscript Online |
|
2016-10-31 09:01 |
| ISSN |
2150-5349 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of Helicobacter pylori
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shinya Yamada, Takumi Kawakami, Yoshikazu Nakatsugawa, Takahiro Suzuki, Hideki Fujii, Naoya Tomatsuri, Hideki Nakamura, Hideki Sato, Yusuke Okuyama, Hiroyuki Kimura and Norimasa Yoshida |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Shinya Yamada, Department of Gastroenterology, Japanese Red Cross Kyoto Daiichi Hospital, Hon-machi 15-749, Kyoto 605-0981, Japan. syo335@koto.kpu-m.ac.jp |
| Key Words |
Helicobacter pylori; Eradication; Vonoprazan; Chronic gastritis; Potassium ion-competitive acid blocker |
| Core Tip |
Use of vonoprazan, a potassium ion-competitive acid blocker, is expected to achieve a higher eradication rate than conventional triple therapy. The success rates of the 2 regimens (use of proton pump inhibitor vs vonoprazan) were compared. The success rate of primary Helicobacter pylori (H. pylori) eradication was significantly higher in the vonoprazan group. When stratified by the underlying disease, a significant increase of the H. pylori eradication rate was observed in patients with chronic gastritis. Vonoprazan is very useful for primary eradication of H. pylori, and may become a first-line acid secretion inhibitor instead of proton pump inhibitors. |
| Publish Date |
2016-10-31 09:01 |
| Citation |
Yamada S, Kawakami T, Nakatsugawa Y, Suzuki T, Fujii H, Tomatsuri N, Nakamura H, Sato H, Okuyama Y, Kimura H, Yoshida N. Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of Helicobacter pylori. World J Gastrointest Pharmacol Ther 2016; 7(4): 550-555
|
| URL |
http://www.wjgnet.com/2150-5349/full/v7/i4/550.htm |
| DOI |
http://dx.doi.org/10.4292/wjgpt.v7.i4.550 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
